Dean J. Warras Sells 10,000 Shares of Phibro Animal Health Corp (PAHC) Stock

Phibro Animal Health Corp (NASDAQ:PAHC) insider Dean J. Warras sold 10,000 shares of the stock in a transaction on Friday, February 9th. The stock was sold at an average price of $35.62, for a total value of $356,200.00. Following the sale, the insider now owns 10,000 shares of the company’s stock, valued at $356,200. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Phibro Animal Health Corp (NASDAQ PAHC) opened at $35.65 on Thursday. Phibro Animal Health Corp has a 1-year low of $26.70 and a 1-year high of $40.25. The company has a current ratio of 3.12, a quick ratio of 1.75 and a debt-to-equity ratio of 1.82. The firm has a market capitalization of $1,408.69, a PE ratio of 22.18, a price-to-earnings-growth ratio of 2.49 and a beta of 1.18.

Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Monday, February 5th. The company reported $0.44 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.06. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The company had revenue of $205.90 million for the quarter, compared to analyst estimates of $194.90 million. During the same period last year, the company earned $0.39 earnings per share. The business’s revenue was up 7.5% compared to the same quarter last year. equities research analysts anticipate that Phibro Animal Health Corp will post 1.69 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be issued a dividend of $0.10 per share. The ex-dividend date is Tuesday, March 6th. This represents a $0.40 annualized dividend and a yield of 1.12%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 26.14%.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Millennium Management LLC raised its holdings in Phibro Animal Health by 64.3% during the fourth quarter. Millennium Management LLC now owns 419,998 shares of the company’s stock valued at $14,070,000 after buying an additional 164,424 shares in the last quarter. Teachers Advisors LLC raised its holdings in Phibro Animal Health by 1.6% during the fourth quarter. Teachers Advisors LLC now owns 352,700 shares of the company’s stock valued at $11,815,000 after buying an additional 5,692 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in Phibro Animal Health by 17.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock valued at $15,959,000 after buying an additional 69,063 shares in the last quarter. Stone Ridge Asset Management LLC bought a new position in Phibro Animal Health during the fourth quarter valued at about $568,000. Finally, Cornercap Investment Counsel Inc. bought a new position in Phibro Animal Health during the fourth quarter valued at about $726,000. Institutional investors own 48.42% of the company’s stock.

PAHC has been the subject of several recent research reports. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. BidaskClub lowered Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Saturday, December 2nd. ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Piper Jaffray Companies reiterated a “buy” rating and set a $42.00 price objective on shares of Phibro Animal Health in a report on Friday, November 10th. Finally, Credit Suisse Group increased their price objective on Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a report on Tuesday, February 6th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $38.20.

COPYRIGHT VIOLATION NOTICE: This report was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://www.chaffeybreeze.com/2018/02/15/dean-j-warras-sells-10000-shares-of-phibro-animal-health-corp-pahc-stock.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply